[Federal Register Volume 85, Number 33 (Wednesday, February 19, 2020)]
[Notices]
[Page 9484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03177]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
March 30-31, 2020. A sample of agenda items to be discussed during the
public session includes:
(1) A discussion on medical-related events; (2) a discussion on the
ACMUI's recommendations regarding the definition of patient
intervention and other actions exclusive of medical events; (3) a
discussion on the U.S. Federal Drug Administration's regulatory process
for drugs and devices; (4) a discussion on the overview of the NRC's
Nuclear Material Events Database; (5) a discussion on the status of
emerging and trending radiopharmaceuticals; and (6) a discussion on the
ACMUI's recommendations on the need for an interventional radiologist
representative position on the ACMUI.
The agenda is subject to change. The current agenda and any updates
will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html or by emailing Ms. Kellee Jamerson at the
contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time: March 30, 2020 from 8:30 a.m. to 2:45 p.m. and March
31, 2020 from 8:30 a.m. to 2:00 p.m. Eastern Standard Time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T-2D30, 11545 Rockville Pike,
Rockville, Maryland 20852.
Public Participation: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Jamerson using the information below. The meeting will also be webcast
live from the NRC's Webcast Portal at https://video.nrc.gov/ gov/. Contact
Information: Ms. Kellee Jamerson, email: [email protected],
telephone: (301) 415-7408.
Conduct of the Meeting
Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson using the contact information listed
above. All submittals must be received by March 25, 2020, three
business days before the meeting, and must pertain to the topics on the
agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
the ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about May 12, 2020.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 12th day of February, 2020.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-03177 Filed 2-18-20; 8:45 am]
BILLING CODE 7590-01-P